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A B S T R A C T
Environmental pollutants like fine particulate matter can cause adverse health effects through oxidative stress
and inflammation. Reactive oxygen and nitrogen species (ROS/RNS) such as peroxynitrite can chemically
modify proteins, but the effects of such modifications on the immune system and human health are not well
understood. In the course of inflammatory processes, the Toll-like receptor 4 (TLR4) can sense damage-asso-
ciated molecular patterns (DAMPs). Here, we investigate how the TLR4 response and pro-inflammatory potential
of the proteinous DAMPs α-Synuclein (α-Syn), heat shock protein 60 (HSP60), and high-mobility-group box 1
protein (HMGB1), which are relevant in neurodegenerative and cardiovascular diseases, changes upon chemical
modification with peroxynitrite.
For the peroxynitrite-modified proteins, we found a strongly enhanced activation of TLR4 and the pro-in-
flammatory transcription factor NF-κB in stable reporter cell lines as well as increased mRNA expression and
secretion of the pro-inflammatory cytokines TNF-α, IL-1β, and IL-8 in human monocytes (THP-1). This enhanced
activation of innate immunity via TLR4 is mediated by covalent chemical modifications of the studied DAMPs.
Our results show that proteinous DAMPs modified by peroxynitrite more potently amplify inflammation via
TLR4 activation than the native DAMPs, and provide first evidence that such modifications can directly enhance
innate immune responses via a defined receptor. These findings suggest that environmental pollutants and re-
lated ROS/RNS may play a role in promoting acute and chronic inflammatory disorders by structurally mod-
ifying the body's own DAMPs. This may have important consequences for chronic neurodegenerative, cardio-
vascular or gastrointestinal diseases that are prevalent in modern societies, and calls for action, to improve air
quality and climate in the Anthropocene.
1. Introduction
Reactive oxygen and nitrogen species (ROS/RNS) like peroxynitrite
play important roles in oxidative stress and adverse health effects in-
duced upon exposure to environmental pollutants and in the course of
inflammatory diseases [1–4]. Peroxynitrite (ONO2−) is generated upon
reaction of superoxide (O2−) and nitric oxide (NO) [5]. It can react with
amino acids like tyrosine, leading to the formation of nitrotyrosine,
dityrosine, and protein oligomers [6–8]. Nitrotyrosine and dityrosine
are known as markers of inflammation and oxidative stress, which can
influence the chemical and physiological properties of proteins [9–11].
For example, nitration can change the binding of proteins to certain
receptors and thus modulate downstream signaling cascades [7,12,13].
Notably, preferential recognition of nitrotyrosine epitopes by
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immunoglobulins was reported for several inflammatory diseases
[14–16]. Dityrosine crosslinks can be intra- or intermolecular, altering
protein structures, causing protein aggregation/oligomerization, and
affecting protein function [17,18].
During inflammation, damage-associated molecular patterns
(DAMPs) can be actively secreted by epithelial cells, monocytes, mac-
rophages, and other cells, or passively released by damaged and dying
cells [19]. Proteinous DAMPs can have various intracellular functions,
e.g., as chaperones, and when released as extracellular proteins, they
can stimulate pattern recognition receptors (PRR) such as the Toll-like
receptor 4 (TLR4) [20]. TLR4 signaling leads to the activation of
transcription factors like the nuclear factor ‘kappa-light-chain-en-
hancer’ of activated B-cells (NF-κB) and the interferon regulatory
transcription factor 3 (IRF3), which are key activators of inflammatory
cascades [21]. NF-κB induces the expression and modulates the secre-
tion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-8,
which can stimulate the corresponding cytokine receptors leading to
further activation of NF-κB and other signaling pathways [22–25]. This
positive feedback can amplify and propagate inflammatory processes in
autocrine or paracrine fashion [26,27].
In this study, we investigate if and how peroxynitrite can enhance
the activation of TLR4 and NF-κB by chemical modification of disease-
related proteins acting as DAMPs (Table S1): α-Synuclein, heat shock
protein 60, and high-mobility-group box 1 protein.
α-Synuclein (α-Syn) is a neuronal protein that regulates exocytosis
and endocytosis of synaptic vesicles as well as ATP synthase [28–30].
Oxidative and nitrating conditions can lead to the formation of nitrated,
misfolded or aggregated α-Syn, which is linked to neurodegenerative
disorders such as Parkinson's disease [31]. Oligomeric and misfolded α-
Syn can be released from neuronal cells by exocytosis and stimulate
TLR4 and other receptors [32,33].
Heat shock protein 60 (HSP60) is a mitochondrial chaperone that
assists correct folding of imported mitochondrial proteins [34]. HSP60
can be released by stressed or necrotic cells, and modulate immune
response by stimulating TLR4 and other receptors [35,36]. It con-
tributes to the pathogenesis of chronic inflammatory diseases such as
Crohn's disease, diabetes, and atherosclerosis [37].
High-mobility-group box 1 protein (HMGB1) is a ubiquitously ex-
pressed nuclear protein involved in DNA replication, recombination,
transcription, and repair [38]. HMGB1 can be released by activated or
damaged cells and secreted by immune cells in response to microbial or
pro-inflammatory stimuli [39]. HMGB1 can stimulate TLR4, the ad-
vanced glycosylation end product-specific receptor (RAGE), and other
receptors [19]. It is involved in severe acute and chronic diseases, such
as sepsis, cancer, cardiovascular and neurodegenerative diseases
[40–42].
The investigated proteins were exposed to peroxynitrite, and cova-
lent chemical modifications were analyzed by liquid chromatography
(HPLC), gel electrophoresis (SDS-PAGE), and western blots (anti-ni-
trotyrosine, anti-dityrosine). TLR4 and NF-κB activation were de-
termined in stable reporter cell lines with bioluminescence detection.
The HeLa TLR4 dual luciferase reporter cell line was used for specific
detection of TLR4 activation and simultaneous determination of cell
viability. The THP-1-Lucia™ NF-κB cell line was used to detect NF-κB
activation via TLR4 or other receptors such as TLR2 and RAGE. Human
monocytes (THP-1) were used to investigate mRNA expression and
secretion of inflammation-related cytokines, such as TNF-α, IL-1β, and
IL-8.
2. Materials and methods
2.1. Protein modification and analysis
2.1.1. Peroxynitrite modification
Protein stock solutions (1 mg mL-1) of α-Syn (Merck Millipore,
Darmstadt, Germany), HSP60 (Abcam, Cambridge, UK), HMGB1
(Sigma Aldrich, Taufkirchen, Germany), and Ovalbumin (InvivoGen,
Toulouse, France) were prepared in PBS (Thermo Fisher Scientific,
Darmstadt, Germany). Ammonium bicarbonate (≥98%, Ph. Eur., BP,
Carl Roth, Karlsruhe, Germany) was dissolved in water to yield a final
buffer concentration of 2 M, and the pH was adjusted to 7.8 by the
addition of 1 M hydrogen chloride (37% stock solution, Merck
Millipore). For each reaction, 300–500 μL protein solution was trans-
ferred into a brown reaction tube (Eppendorf, Hamburg, Germany), and
7.5-12.5 μL ammonium bicarbonate buffer (2 M) was added to yield a
final buffer concentration of 50 mM. After being thawed on ice, 1–8 μL
sodium peroxynitrite solution (160–200 mM, Merck Millipore) was
added to yield a molar ratio of peroxynitrite to tyrosine residues of 5:1,
and the reaction was performed on ice for 110 min. Thereafter, the
sample was pipetted into a 10 kDa centrifugal filter (Amicon®, Merck
Millipore) and centrifuged at 14,000×g for 2 min (5427 R, Eppendorf).
The sample was washed five times with 200 μL PBS and centrifugation
at 14,000×g for 2 min. For sample recovery, the filter was turned
upside down, transferred into a clean microcentrifuge tube, and cen-
trifuged at 1000×g for 2 min. To recover possible sample residues, the
filter was washed with 200 μL fresh PBS and centrifuged upside down at
1000×g for 2 min into the concentrated protein sample. Ovalbumin
(OVA), which is not a TLR4 agonist, was treated the same way and
served as negative control in the cell culture experiments described
below. For mock samples, 500 μL pure PBS was mixed with 12.5 μL
ammonium bicarbonate buffer (2 M) and 8 μL peroxynitrite and treated
as described above.
Protein concentrations were determined using a Synergy Neo plate
reader (BioTek, Bad Friedrichshall, Germany) measuring the absor-
bance at 260 nm/280 nm. For each protein, a dilution series of the
native protein (25–1000 μg mL-1) was used for calibration. Three mi-
croliters of modified protein solution were transferred into a micro-
volume plate in triplicates (Take3 trio, BioTek), and the absorbance was
measured. The protein concentrations were confirmed by SDS-PAGE
and silver stain (see section 2.1.3).
For each of the investigated proteins, multiple samples of protein
solution were chemically modified as outlined above, and selected
samples were characterized by the analytical methods described below.
An overview of the analytical results is given in Table S2 (tyrosine ni-
tration degree, dimer fraction).
2.1.2. HPLC-DAD analysis
For the investigated proteins, tyrosine nitration degrees were de-
termined as described in Selzle et al. [43]. Briefly, an HPLC−DAD
system (Agilent Technologies 1260 Infinity series, Waldbronn, Ger-
many) equipped with a monomerically bound C18 column (Vydac
238 TP, 250 mm × 2.1 mm i.d., 5 μm, Hichrom, Berkshire, UK) was
used for chromatographic separation. Gradient elution was performed
with 0.1% (v/v) trifluoroacetic acid in water (VWR International
GmbH, Darmstadt, Germany) and acetonitrile (Carl Roth), and absor-
bance was measured at wavelengths of 280 nm and 357 nm. Injection
volume was 10 μL, and each chromatographic run was performed in
duplicates. For system control and data analysis, ChemStation Software
Abbreviations
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was used (Rev. C.01.07, Agilent). Nitration was observed in the mod-
ified samples of all proteins, and tyrosine nitration degrees were
quantified in two independent experiments as specified in Table S2. The
tyrosine nitration degree is defined as the concentration of nitrotyrosine
divided by the sum of the concentrations of nitrotyrosine and tyrosine
[43].
2.1.3. SDS-PAGE and silver stain
Protein oligomerization was visualized and quantified by silver
stained SDS-PAGE (Thermo Fisher Scientific). Protein samples dissolved
in PBS were mixed with an equivalent volume of 2x Laemmli buffer,
containing 65.8 mM Tris-HCl (pH 6.8, Carl Roth), 26.3% glycerol (v/v,
Carl Roth), 2.1% SDS (Carl Roth), 0.02% bromophenol blue (Sigma
Aldrich) and 5.0% 2-mercaptoethanol (Sigma Aldrich), and heated at
95 °C for 5 min. The samples (50 ng in 10 μL) were loaded onto
PROTEAN Precast gels (4–20%, Bio-Rad, Munich, Germany) together
with 10 ng Color Prestained Protein Standard, Broad Range
(11–245 kDa, New-England Biolabs, Frankfurt, Germany) and stained
with a silver stain kit (Thermo Fisher Scientific) following manufac-
turer's instructions. For image acquisition and quantification of protein
monomers, dimers, and higher oligomers, a ChemiDoc system (Bio-Rad)
with Image Lab software 5.2.1 (Bio-Rad) was used. Protein dimers oc-
curred in the modified samples of all proteins (Fig. S1, Table S2), and
signals of higher oligomers were observed but exceeded the analytical
detection limit (3%) only for modified HSP60 (23 ± 13%).
2.1.4. Western blot analysis
The presence of nitrotyrosine and dityrosine residues was in-
vestigated by SDS-PAGE and subsequent Western blot analysis. The
native and modified protein samples were prepared in Laemmli-buffer
as described in section 2.1.3. As sensitivities for the antibodies varied,
different amounts of protein per lane were applied for nitrotyrosine
staining (2 μg α-Syn, 5 μg HSP60, and 10 μg HMGB1) and dityrosine
staining (5 μg α-Syn, 5 μg HSP60, and 5 μg HMGB1). For nitrotyrosine
staining, α-Syn, HSP60, and HMGB1 were separated by a 12%, 8%, and
10% SDS polyacrylamide gel, respectively, and by a Mini-PROTEAN
Precast gel (4–20%, Bio-Rad) for dityrosine staining. Thereafter, the
gels were transferred onto 0.45 μm PVDF membranes (Merck Millipore)
using a semi-dry transfer unit (Hoefer, Holliston, MA, USA). The
membranes were blocked with 5% fat-free milk powder (Cell Signaling
Technology, Leiden, Netherlands) in Tris-buffered saline with 0.1%
Tween-20 (TBS-T) at RT for 2 h, followed by an overnight incubation at
4 °C with nitrotyrosine antibody (mouse monoclonal [clone HM11],
1:1000, Cat # 321,900, Thermo Fisher Scientific) and dityrosine anti-
body (mouse monoclonal [clone 7D4], 1:10,000, Cat # NBP2-59360,
Novus Biologicals, Centennial, CO, USA), respectively, diluted in 5%
fat-free milk powder in TBS-T. All membranes were washed four times
with TBS-T for 5 min each and incubated with the horseradish perox-
idase coupled secondary antibody (goat anti-mouse, polyclonal,
1:10,000, Cat # 115-035-062, Jackson Immuno Research Europe Ltd,
Ely, UK) at RT for 1 h, diluted in TBS-T. For detection, the membranes
were washed four times with TBS-T for 5 min, and protein bands were
developed using the chemiluminescence system ECL-femto (Thermo
Fisher Scientific) for nitrotyrosine and ECL-plus (Thermo Fisher Sci-
entific) for dityrosine according to the manufacturer's protocol. The
bands were detected in a ChemiDoc system, and images were processed
using Image Lab software 5.2.1. Nitrotyrosine and dityrosine were de-
tected in peroxynitrite-modified samples of all investigated proteins.
For the native proteins, neither nitrotyrosine nor dityrosine were de-
tectable in the western blots (Fig. S1).
2.1.5. Endotoxin quantification
The amount of endotoxin in native and modified protein samples
was quantified by a Pierce™ LAL Chromogenic Endotoxin Quantitation
Kit (Thermo Fisher Scientific) according to the manufacturer's protocol.
For this purpose, protein stock solutions were diluted to 1 μg mL-1 with
endotoxin-free water. The endotoxin level in all protein samples was
less than 1 EU per μg of protein.
2.2. Cell culture experiments
All cell experiments were performed with the same final con-
centrations of native and modified protein samples (α-Syn: 50.0 μg mL-
1, HSP60: 14.3 μg mL-1, HMGB1: 3.6 μg mL-1, OVA: 50.0 μg mL-1) ex-
cept for mRNA expression of α-Syn (35.7 μg mL-1). LPS from E. coli
O111:B4, 25 ng mL-1, InvivoGen) was used as positive control (LPS-EB
for HeLa TLR4 experiments; LPS-EB ultrapure for THP-1-Lucia™ and
THP-1 experiments), and medium and mock served as negative con-
trols. Protein solutions were diluted in the respective cell culture
medium.
2.2.1. HeLa TLR4 dual reporter cells
Using an immortalized and further modified HeLa TLR4 dual luci-
ferase reporter cell line (Novus Biologicals), we simultaneously de-
termined TLR4 activation and cell viability [8]. HeLa is a human epi-
thelial cervix cell line, which is not known to express functional
receptors of TLR4, TLR2 or RAGE. The stably transfected TLR4/MD-2/
CD14/IL-8 Prom/LUCPorter™ reporter cell line expresses human TLR4
(Novus Biologicals). This cell line was further stably co-transfected with
a Renilla luciferase reporter gene under the transcriptional control of an
IL-8 promoter [8] serving as a surrogate marker for viability to in-
vestigate both TLR4 activation and cell viability simultaneously. Cells
were grown in Dulbecco's Modified Eagle's Medium (DMEM, Thermo
Fisher Scientific) containing 25 mM D-glucose and 1 mM sodium pyr-
uvate supplemented with 10% heat-inactivated fetal bovine serum (FBS
superior, Cat #S0615, Lot #0973F, Biochrom, Berlin, Germany), 1%
penicillin/streptomycin (Thermo Fisher Scientific) and 140 μg mL-1
hygromycin B (InvivoGen) in a humidified atmosphere of 5% CO2 at
37 °C. For each sample and replicate, 20,000 HeLa TLR4 dual reporter
cells in 100 μL medium per well were seeded in a flat-bottom 96-well
plate (Greiner, Frickenhausen, Germany). After 24 h, the cells were
incubated in triplicates with 50 μL of the respective protein or control
sample for 7 h. Thereafter, cells were washed with 200 μL PBS and lysed
using 15 μL passive lysis buffer (Promega, Mannheim, Germany) at
-80 °C overnight. The read out was performed using the Dual-Luci-
ferase® Reporter Assay System (Promega) according to the manufac-
turer's protocol. Both luminescence signals were measured in a Synergy
Neo plate reader. To calculate the normalized TLR4 activity, TLR4-
driven Renilla luciferase signal was divided by the constitutive, CMV-
driven firefly luciferase signal that served as a surrogate marker for cell
viability. For each experiment, LPS-treated cells were used as a positive
control, and the arithmetic mean was set to 100%. This value was used
to normalize the measurement results of all protein and control sam-
ples. Arithmetic mean values and standard deviations were calculated
from the normalized values of three (HSP60) or four (α-Syn, HMGB1,
OVA) independent experiments performed in triplicates.
2.2.2. THP-1 NF-κB reporter cells and receptor antagonists
THP-1-Lucia™ NF-κB (InvivoGen) is an immortalized modified THP-
1 cell line allowing the determination of NF-κB activation by measuring
the activity of secreted luciferase. We used this cell line to determine
the activation of NF-κB after treatment with native and peroxynitrite-
modified proteins, regardless of the receptors involved in the activation
(TLR4, TLR2, RAGE). Cells were grown in Roswell Park Memorial
Institute (RPMI) 1640 medium (Thermo Fisher Scientific) containing
25 mM D-glucose and 1 mM sodium pyruvate supplemented with 10%
heat-inactivated FBS, 100 μg mL-1 Zeocin™ (InvivoGen), and 1% peni-
cillin/streptomycin in a humidified atmosphere of 5% CO2 at 37 °C. For
each sample and replicate, 100,000 cells in 50 μL medium per well were
seeded in a flat-bottom 96-well plate. To inhibit TLR4 or RAGE sig-
naling, cells were pre-incubated with 50 μL of the TLR4 antagonist TAK-
242 or the RAGE antagonist FPS-ZM1 for 4 h. TAK-242 (25 mM, Merck
K. Ziegler, et al. Redox Biology 37 (2020) 101581
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Millipore) was provided in dimethyl sulfoxide (DMSO) and further di-
luted with medium to a final concentration of 0.36 μg mL-1. FPS-ZM1
(25 mg, Merck Millipore) was dissolved in 250 μL DMSO and further
diluted with medium to a final concentration of 3.3 μg mL-1. If no an-
tagonist was applied, 50 μL medium was added to the cells.
Subsequently, cells were incubated in triplicates with 50 μL of the re-
spective protein or control samples for 24 h. Cells treated with DMSO in
medium (4.4 μg mL-1) showed no NF-κB activation or toxic effects.
Activity of NF-κB was measured by QUANTI-Luc™ reagent (InvivoGen)
according to manufacturer's instructions. Briefly, 10 μL of cell culture
supernatant was transferred into a white plate (LUMITRAC™, Greiner),
and mixed with 50 μL of QUANTI-Luc™ reagent. The luminescence was
detected in a Synergy Neo plate reader. For each experiment, LPS-
treated cells were used as positive control, and the arithmetic mean was
set to 100%. This value was used to normalize the measurement results
of all protein and control samples. Arithmetic mean values and standard
deviation were calculated from the normalized values of three (α-Syn)
or four (HSP60, HMGB1, OVA) independent experiments performed in
triplicates. Assessment of cell viability was performed in triplicates
using the alamarBlue™ cell viability reagent (Thermo Fisher Scientific)
according to the manufacturer's protocol. Excitation was performed at
560 nm, and emission was measured at 590 nm in a Synergy Neo plate
reader.
2.2.3. Cytokine immunoassay
Immortalized human THP-1 monocyte cells (ATCC, Manassas, VA,
USA) were used as typical monocytes producing inflammation-related
cytokines such as TNF-α, IL-1β, and IL-8. THP-1 monocytes express
functional TLR4, TLR2, and RAGE, whose activation leads to NF-κB
activation and subsequent production and release of cytokines. Cells
were grown in RPMI 1640 medium supplemented with 10% heat-in-
activated FBS, 0.05 mM 2-mercaptoethanol (Sigma Aldrich), and 1%
penicillin/streptomycin. Quantification of cytokine secretion was per-
formed using a multiplex immunoassay. For each sample and replicate,
100,000 human THP-1 monocytes in 100 μL medium per well were
seeded in a flat-bottom 96-well plate (Greiner) and incubated in tri-
plicates with 50 μL of the respective protein or control samples over
24 h. Thereafter, cells were centrifuged at 200×g for 5 min (5427 R,
Eppendorf), and the supernatants of the triplicates were combined and
analyzed in duplicates for TNF-α, IL-1β, and IL-8 by a multiplex assay
kit (R&D systems Inc., Minneapolis, MN, USA) according to the man-
ufacturer's protocol. The read-out was performed on a MAGPIX device
(Luminex, Austin, TX, USA), and arithmetic mean values and standard
deviation of the duplicates were calculated. Three experiments were
performed (first two with same supernatant) and showed similar trends.
Assessment of cell viability was performed as described in section 2.2.2.
2.2.4. mRNA extraction and qPCR analysis
Quantification of mRNA expression of TNF-α, IL-1β, IL-8, and CXCL-
10 was performed using real-time quantitative PCR (qPCR). For each
sample, 400,000 human THP-1 monocyte cells in 1 mL medium per
well were seeded in a 6-well cell culture plate (Greiner). On the next
day, cells were incubated with 1 mL of the respective protein or control
samples for 4 h. For qPCR analysis, cells were harvested by cen-
trifugation at 500×g for 5 min. Total RNA was extracted from cells
using RNeasy Mini Kit (Qiagen, Hilden, Germany) following the spin
technology protocol. Total RNA yield was determined using a Take3
trio micro-volume plate in a Synergy Neo plate reader. Using the High
Fig. 1. TLR4 activation by native and peroxynitrite-modified proteins. TLR4 activity in HeLa TLR4 dual luciferase reporter cells determined for α-Syn (A),
HSP60 (B), HMGB1 (C), and OVA (D) normalized to LPS. Arithmetic mean values and standard deviations of three to four independent experiments performed in
triplicates (*p < 0.05, **p < 0.01).
K. Ziegler, et al. Redox Biology 37 (2020) 101581
4
Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific),
500 ng of total RNA per sample were transcribed into cDNA.
Afterwards, qPCR was performed in duplicates using 10 ng of cDNA
mixed with SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) to
a final concentration of 333 nM for each primer, which were designed
using PrimerBlast (NCBI) and the respective template genes (Table S3).
As reference genes served peptidylprolyl isomerase A (PPIA) and TATA-
binding protein (TBP). Reactions were performed at 98 °C for 30 s,
followed by 37 cycles of 98 °C for 10 s, and 60 °C for 25 s. Gene ex-
pression was calculated according to the 2−ΔΔCT method using the Bio-
Rad CFX Manager Software 3.1. Arithmetic mean values and standard
deviation of the duplicates were calculated. Three independent ex-
periments were performed showing similar trends.
2.2.5. Statistical analyses
GraphPad Prism version 6.07 (GraphPad, San Diego, CA, USA) was
used for statistical analysis. Unpaired t-tests were performed to observe
differences between the native and peroxynitrite-modified proteins.
The results were considered as significant when *p < 0.05,
**p < 0.01, ***p < 0.005.
3. Results
For the investigated proteins in native and peroxynitrite-modified
form, TLR4 and NF-κB activation were determined in stable reporter
cell lines. The HeLa TLR4 dual luciferase reporter cell line was used for
specific detection of TLR4 activation and simultaneous determination
of cell viability, while the THP-1-Lucia™ NF-κB cell line was used to
detect NF-κB activation. Additionally, mRNA expression and secretion
of inflammation-related cytokines induced by NF-κB were measured in
human monocytes (THP-1).
As shown in Figs. 1 and 2, chemical modification by peroxynitrite
significantly increased activation of TLR4 and NF-κB for all three in-
vestigated proteins. Relative to the native protein, the TLR4 activity
increased by a factor of ~1.4 for α-Syn and HSP60 and by a factor of
~2.2 for HMGB1 (Fig. 1, Table S4), while the NF-κB activity increased
by a factor of ~1.6 for α-Syn and HSP60 and by a factor of ~4.2 for
HMGB1 (Fig. 2, Table S4). Inhibition of TLR4 by the antagonist TAK-
242 reduced the NF-κB response to both, the modified and native
protein, by more than 80% for α-Syn, by more than 90% for HSP60, and
by 30–40% for HMGB1, while the RAGE inhibitor FPS-ZM1 had no
substantial effect (Fig. 2). These inhibition experiments indicate that
the enhancement of NF-κB activation by peroxynitrite-modification is
predominantly mediated by TLR4 for α-Syn and HSP60, while for
HMGB1 also other receptors such as RAGE and TLR2 may be involved
[44,45].
Fig. 3 shows that the chemically modified proteins also enhanced
the secretion of the pro-inflammatory cytokines TNF-α, IL-1β, and IL-8.
Relative to the native protein, the secretion increased 1.2-2.0 fold for α-
Syn, 1.2-8.8 fold for HSP60, and 2.1-16.7 fold for HMGB1 (Table S5).
The mRNA expression of the investigated cytokines showed the same
trend for modified HSP60 and HMGB1, but not for modified α-Syn (Fig.
S2, Table S6). The mRNA results obtained for CXCL-10 indicate that the
chemically modified proteins increased not only the activation of NF-κB
(MyD88 pathway), but also the activation of the IRF3 (TRIF/TRAF)
pathway of TLR4 signaling [50,51]. The negative controls of native and
peroxynitrite-modified OVA exhibited no substantial TLR4 and NF-κB
activity, cytokine secretion, or mRNA expression (Figs. 1–3, Fig. S2),
and the applied protein concentrations did not affect the viability of the
investigated cells (Figs. S3–S5), suggesting that the induced protein
modifications were only relevant in the context of the TLR4-activating
proteins. Pro-inflammatory cytokine responses via TLR4 are often het-
erogeneous at both the cell and population level [46–50], which pro-
vides an explanation for the variability of enhancement factors ob-
tained from the cytokine expression and secretion experiments in this
study (Tables S5 and S6). Nevertheless, the basic effects and overall
trends observed for chemically modified vs. native DAMPs were con-
sistent throughout our investigations - not only among replicate ex-
periments but also with regard to the different experiments performed
and different techniques applied in our study, which supports the main
findings and conclusions as summarized and discussed below. Further
investigations with larger replicate numbers and other cell types (pri-
mary cells) will be required for improved quantification of the cytokine
effects and further mechanistic insights.
Overall, the available experimental results demonstrate that per-
oxynitrite treatment enhances the inflammatory potential of α-Syn,
Fig. 2. NF-κB activation by native and peroxynitrite-modified proteins. NF-κB activity in THP-1-Lucia™ NF-κB cells determined for α-Syn (A), HSP60 (B),
HMGB1 (C), and OVA (D) normalized to LPS. Inhibition experiments with TLR4 antagonist TAK-242 and RAGE antagonist FPS-ZM1. Arithmetic mean values and
standard deviations of three to four independent experiments performed in triplicates (*p < 0.05, **p < 0.01).
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HSP60, and HMGB1 in vitro. This can be explained by changes in pro-
tein-receptor interactions related to chemical modifications like ni-
trotyrosine, intramolecular dityrosine crosslinks, protein dimers and
higher oligomers as detected in the peroxynitrite-modified samples of
the investigated proteins.
4. Discussion
Nitrotyrosine was detected in all chemically modified protein sam-
ples (Fig. S1, Table S2), and the introduction of a nitro group can
strongly affect the chemical and physiological properties of a protein
[52]. Notably, nitrotyrosine is more acidic than tyrosine, which can
affect the isoelectric point of a protein, change the binding to receptors
and ligands, and modulate downstream signaling cascades
[7,12,13,53,54]. Nitration tends to enhance the immunogenicity of
proteins, and nitrated proteins are thus used as model antigens or al-
lergens [15,16,55–60]. The reason for this striking immunological
property of nitrated proteins, which has also been linked to auto-
immunity, is not completely clear [9,61]. The generation of neo-epi-
topes seems to be an important factor in adaptive immune responses
[12,15], and nitrotyrosine was found to be associated with increased
TLR4 signaling and innate immune responses related to chronic in-
flammatory diseases [8,52,62–64]. However, we here show for the first
time that there is a direct enhancement of TLR4 activation by the
peroxynitrite-induced modification of natural (human) DAMPs that
play a role as innate immune activators in acute and chronic in-
flammation.
Besides nitrotyrosine, also dityrosine was detected in all chemically
modified protein samples (Fig. S1). The detection of dityrosine in the
monomeric form of the modified proteins implies that intramolecular
crosslinks were formed and may have induced conformational changes
affecting protein-receptor interactions. For HMGB1, it is well known
that TLR4 binding depends on the oxidation state of the protein, and
that an intramolecular disulfide bridge is crucial for TLR4 dimerization
and activation [65,66]. By analogy, intramolecular dityrosine crosslinks
among the tyrosine residues in HMGB1 might also induce or stabilize
conformational arrangements that are relevant for protein-receptor
interactions and TLR4 activation. Further investigations will be re-
quired to clarify if and how intramolecular dityrosine crosslinks may
contribute to the enhancement of TLR4 activity observed for perox-
ynitrite-modified HMGB1 and other proteins.
Protein dimers and higher oligomers were detected in all chemically
modified protein samples (Fig. S1, Table S2). They comprise more than
Fig. 3. Pro-inflammatory cytokine secretion in response to native and peroxynitrite-modified proteins. Release of TNF-α (A), IL-1β (B), and IL-8 (C) de-
termined for THP-1 monocytes after incubation over 24 h. Data for mock, medium, and OVA/mod-OVA are near or below the relevant limits of detection
(~2–20 pg mL-1). Arithmetic mean values and standard deviations of a representative experiment performed in technical duplicates (*p < 0.05, **p < 0.01,
***p < 0.005).
Fig. 4. Amplification of inflammatory processes and innate immune re-
sponses through chemically modified DAMPs. Environmental pollutants and
oxidative stress can induce an increase of reactive oxygen and nitrogen species
(ROS/RNS), the formation of chemically modified damage-associated mole-
cular patterns (mod-DAMPs), an increase of pro-inflammatory signaling via
Toll-like receptors and other pattern recognition receptors (TLR/PRR), an in-
crease of proinflammatory cytokines, and further inflammatory cellular re-
sponses. Note that the results of this study and the schematic illustration are
based on experiments with immortalized cell lines, and that further experi-
ments with primary cells are required to confirm their applicability to the
human immune system.
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one receptor interaction domain, can act as multivalent ligands, and
may thus more efficiently promote TLR4 dimerization and signaling
[8,67–69]. Such multivalency effects are common in biological systems,
where higher functional affinities are observed for dimeric and oligo-
meric agonists, leading to enhanced receptor clustering and signal
transduction [70,71]. Thus, the formation of dimers and oligomers by
intermolecular dityrosine crosslinking may well explain the enhanced
TLR4 and NF-κB activity observed upon stimulation with peroxynitrite-
modified samples compared to the native form of the investigated
proteins. For α-Syn, this is consistent with earlier studies reporting that
oligomeric α-Syn can enhance TLR4 signaling and pro-inflammatory
cytokine production in microglia and astrocytes, which may contribute
to development and progression of Parkinson's disease [32,72]. Similar
effects have been reported for the interaction of amyloid beta in Alz-
heimer's disease, where aggregates trigger TLR2 and TLR4 [73,74], and
nitration critically enhances amyloid beta aggregation and plaque for-
mation [75]. For all receptors within the TLR family [76,77] as well as
RAGE [78,79] and other receptors [80,81], activation and signal
transduction requires dimerization of the receptor molecules, which
may be promoted by dimeric or oligomeric ligands. Thus, we suggest
that the peroxynitrite-induced dimerization or oligomerization of
HSP60 and HMGB1 may also play a critical role for PRR signaling in
inflammatory diseases.
As outlined above, the proteins α-Syn, HSP60, and HMGB1 are in-
volved in many severe diseases. If in vivo studies confirm that ni-
trotyrosine residues or dityrosine crosslinks in proteinous DAMPs play
an important role in amplifying inflammatory processes through en-
hanced TLR4 signaling, the chemically modified proteins may serve as
useful clinical markers providing mechanistic insights. Such markers
and insight may also help to advance medical treatment options that
involve scavenging of peroxynitrite [82–84] or the inhibition of per-
oxynitrite formation [85].
5. Conclusions
In this study, we have shown that peroxynitrite can induce chemical
modifications that enhance the TLR4 activity and inflammatory po-
tential of proteinous DAMPs like α-Syn, HSP60, and HMGB1.
Besides peroxynitrite, a wide range of other endogenous or exo-
genous ROS/RNS can also modify the chemical structure, properties,
and effects of proteins [18]. In particular, air pollutants such as fine
particulate matter, nitrogen oxides, and ozone can trigger or enhance
oxidative stress, nitration and oligomerization of proteinous DAMPs
and allergens, immune reactions, and feedback cycles of inflammation
[1,8,27,55,56,86–88].
Fig. 4 illustrates how chemically modified DAMPs may amplify
oxidative stress and innate immune responses through a positive feed-
back loop of pro-inflammatory signaling via TLR4 or other PRR. Such
feedback and self-amplification provide a potential mechanistic ratio-
nale for the development of inflammatory disorders related to en-
vironmental pollution. In particular, it may help to explain the massive
burden of disease attributable to air pollution, where the underlying
chemical and physiological mechanisms are not yet well understood
[4,89,90]. Environmental pollutants may generate exogenous ROS/RNS
and oxidative stress, triggering inflammatory processes that lead to the
formation of endogenous ROS/RNS and release of DAMPs. The DAMPs
can activate PRR (TLR, RAGE, etc.) that induce further pro-in-
flammatory signaling and responses via transcription factors (NF-κB,
IRF3, etc.), cytokines and cytokine receptors (IL-1, IL-8, etc.). This
positive feedback can be additionally enhanced if the DAMPs undergo
chemical modification by ROS/RNS, and if the modified DAMPs lead to
stronger activation of PRR than the native DAMPs, as observed in this
study. Such effects may have important consequences for chronic
neurodegenerative, cardiovascular or gastrointestinal diseases and al-
lergies that are prevalent in modern societies. Note, however, that the
experimental results of this study were obtained with immortalized cell
lines, and that primary cells should be used in follow-up studies to
confirm the obtained data and conclusions with regard to the human
immune system. We suggest and intend to pursue such follow-up stu-
dies further elucidating the underlying chemical and immunological
interactions. Moreover, we suggest to consider and elucidate the role of
environmental pollutants, and potential needs and perspectives for so-
cietal action with regard to the steeply increasing and globally perva-
sive human influence on air quality, climate, and public health in the
Anthropocene [56,91].
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